BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260406T055118
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260309
DTSTAMP:20260406T055118
CREATED:20251113T220524Z
LAST-MODIFIED:20251113T220546Z
UID:10000349-1772755200-1773014399@oncodaily.com
SUMMARY:Pathology Update 2026
DESCRIPTION:Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8\, 2026\, in Sydney\, NSW. \nThe meeting provides a multi-disciplinary pathology program for pathologists\, scientists\, and trainees\, focusing on new developments and challenges in the field under the theme\, “Many Paths. Shared Focus. Stronger Together.” The event will include plenary sessions\, workshops\, and abstract presentations from both local and international pathology experts\, coinciding with the celebration of the RCPA’s 70th anniversary.
URL:https://oncodaily.com/event/pathology-update-408954
LOCATION:International Convention Centre Sydney\, Australia\, 14 Darling Dr\, Sydney NSW 2000\, Australia\, Sydney\, NSW\, 2000\, Australia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/575111358_1424538106348656_696976248818726427_n.jpg
ORGANIZER;CN="Royal College of Pathologists of Australia":MAILTO:rcpa@rcpa.edu.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260309
DTSTAMP:20260406T055118
CREATED:20260120T093429Z
LAST-MODIFIED:20260120T093436Z
UID:10000597-1772755200-1773014399@oncodaily.com
SUMMARY:Best of the 19th St. Gallen International Breast Cancer Conference - India
DESCRIPTION:The Best of the 19th St. Gallen International Breast Cancer Conference – India\, incorporating the Asian Cancer Consensus Meet\, is a premier scientific event scheduled for March 6-8\, 2026\, in Kolkata\, India. \nOrganized by the Institute of Breast Diseases\, Kolkata\, the conference will be held at Taj Taal Kutir and serves as the official regional update to the global St. Gallen Consensus. The program bridges international clinical standards with regional relevance\, featuring a keynote by Prof. Michael Gnant (Co-Chair of SGBCC\, Vienna) and consensus-building sessions tailored for Low- and Middle-Income Countries (LMICs). \nRegister. \nAbstract Submission.
URL:https://oncodaily.com/event/breast-cancer-443868
LOCATION:Taj Taal Kutir\, Kolkata\, No. 11E/65\, Eco Tourism Park\, Eco Park Rd\, AA II\, Deshbandhu Nagar\, New Town (Kolkata)\, West Bengal\, 700156\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Screenshot-2026-01-20-133340.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T080000
DTEND;TZID=America/Halifax:20260308T121500
DTSTAMP:20260406T055118
CREATED:20251218T151631Z
LAST-MODIFIED:20251218T151759Z
UID:10000511-1772784000-1772972100@oncodaily.com
SUMMARY:26th Multidisciplinary Management of Cancers: A Case-Based Approach
DESCRIPTION:The 26th Multidisciplinary Management of Cancers: A Case-Based Approach\, held March 6–8\, 2026\, at the Meritage Resort and Spa\, will focus on the latest multidisciplinary strategies in clinical oncology. \nThe meeting features tumor board–style case discussions across breast\, gastrointestinal\, genitourinary\, hematologic\, lymphoma\, and thoracic cancers\, led by faculty and expert panels from Stanford\, UC Davis\, UC San Francisco\, and the broader oncology community. \nRegister here.
URL:https://oncodaily.com/event/cancers-430551
LOCATION:The Meritage Resort and Spa\, 875 Bordeaux Way\, Napa\, CA\, 94558\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-92-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T090000
DTEND;TZID=America/Halifax:20260306T100000
DTSTAMP:20260406T055118
CREATED:20260306T041816Z
LAST-MODIFIED:20260306T041816Z
UID:10000685-1772787600-1772791200@oncodaily.com
SUMMARY:CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS\,” is scheduled for Friday\, March 06\, 2026\, at 09:00 AM ET (06:00 PM Armenia Standard Time).  \nFeaturing Dr. Valentín Ortiz-Maldonado\, the session will explore the clinical implementation and integration of Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia within the Spanish National Health Service. Organized by Resonance Health\, the event is supported by the leadership team of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a vital platform for the global medical community to evaluate the multicentre\, phase 2 trial data and the logistical frameworks required to move advanced CAR T therapies from experimental stages to standardized hospital care.
URL:https://oncodaily.com/event/resonance-465252
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Gemini_Generated_Image_xebl5mxebl5mxebl-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T130000
DTEND;TZID=America/Halifax:20260307T144500
DTSTAMP:20260406T055118
CREATED:20260114T211734Z
LAST-MODIFIED:20260114T211750Z
UID:10000573-1772802000-1772894700@oncodaily.com
SUMMARY:Australian Precision Oncology Symposium 2026
DESCRIPTION:The Australian Precision Oncology Symposium 2026 (APOS 26) is a two-day scientific event focused on the theme “Mainstreaming Precision Oncology: Transforming Care Through Science\, Medicine and Equity.” \nScheduled for March 6–7\, 2026\, in Sydney\, the symposium serves as a collaborative platform for researchers\, clinicians\, and industry representatives to discuss the integration of genomic medicine into standard cancer care. The program includes technical sessions\, a symposium dinner\, and presentations from a diverse speaking faculty specializing in clinical genomics and molecular oncology. \nRegister.
URL:https://oncodaily.com/event/australian-precision-oncology-441165
LOCATION:John Niland Scientia Building\, G19 Library Rd\, Sydney\, New South Wales\, 2033\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/APOS.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260307
DTEND;VALUE=DATE:20260308
DTSTAMP:20260406T055118
CREATED:20251215T190559Z
LAST-MODIFIED:20251215T190612Z
UID:10000498-1772841600-1772927999@oncodaily.com
SUMMARY:OPN Pacific Northwest Chapter Conference 2026
DESCRIPTION:The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network\, scheduled for March 7\, 2026. \nThe conference will be held at the Crowne Plaza in Portland\, Oregon\, United States. Designed for hematology/oncology pharmacy clinicians\, including pharmacists and technicians\, the event provides a platform to network\, collaborate\, and share the latest evidence-based strategies and best practices to advance patient care within the oncology pharmacy field. \nRegister.
URL:https://oncodaily.com/event/opn-pacific-northwest-429035
LOCATION:Crowne Plaza Portland-Downtown Conv Ctr\, 1441 NE 2nd Ave\, Portland\, OR\, 97232\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-Pacific-Northwest.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
DTSTAMP:20260406T055118
CREATED:20260118T190819Z
LAST-MODIFIED:20260118T190827Z
UID:10000595-1773014400-1773100799@oncodaily.com
SUMMARY:Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies
DESCRIPTION:The webinar “Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies” is a high-level clinical session scheduled for March 9\, 2026\, at 18:00 CET. \nServing as the second installment of a specialized series by SPCC (Sharing Progress in Cancer Care)\, this activity moves beyond foundational knowledge to tackle the most debated aspects of MRD in current oncology. Led by a panel of international experts including Jesús San-Miguel\, Luciano Costa\, and Elena Zamagni\, the discussion will focus on the feasibility of MRD-driven treatment de-escalation\, the challenge of spatial heterogeneity\, and the integration of imaging with molecular techniques.
URL:https://oncodaily.com/event/minimal-residual-disease-443045
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-4.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260311
DTSTAMP:20260406T055118
CREATED:20260105T212607Z
LAST-MODIFIED:20260105T212616Z
UID:10000556-1773014400-1773187199@oncodaily.com
SUMMARY:Cell and Gene Therapy 2026
DESCRIPTION:The ELRIG Cell and Gene Therapy 2026 is a free-to-attend\, two-day scientific conference scheduled for March 9–10\, 2026\, in Cambridge\, UK. \nOrganized by the European Laboratory Research and Innovation Group (ELRIG)\, this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene therapies for neurological disorders\, advancements in sensory disorder treatments\, scaling solutions for rare diseases\, and next-generation cancer immunotherapy. \nThe oncology-specific track\, titled “Engineering the Future of Cancer Immunotherapy: Advances in T Cell Design and Function\,” explores cutting-edge developments in CAR and TCR engineering\, strategies to improve the safety and durability of T-cell therapies\, and technologies aimed at making these treatments more accessible for both hematological and solid malignancies. \nRegister.
URL:https://oncodaily.com/event/cell-and-gene-therapy-437178
LOCATION:Hinxton Hall Conference Centre\, Wellcome Genome Campus\, Hinxton\, Cambridge\, Cambridgeshire\, CB10 1RQ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Cell-and-Gene-Therapy-1.webp
ORGANIZER;CN="European Laboratory Research and Innovation Group (ELRIG)":MAILTO:info@elrig.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260313
DTSTAMP:20260406T055118
CREATED:20260110T230819Z
LAST-MODIFIED:20260110T230836Z
UID:10000565-1773187200-1773359999@oncodaily.com
SUMMARY:2026 NCODA Global Oncology and Haematology Congress
DESCRIPTION:The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology\, hematology\, and technology experts scheduled for March 11–12\, 2026\, in Dublin\, Ireland. \nOrganized by NCODA\, the congress focuses on “bridging innovation and patient-centered care” through collaborative sessions that highlight best practices in medically integrated oncology. The technical program is designed to provide actionable insights into treatment sequencing\, therapy challenge management\, and patient adherence. \nThe event serves as a critical networking hub for physicians\, pharmacists\, nurses\, and industry partners dedicated to streamlining clinical workflows and improving global patient outcomes. \nRegister.
URL:https://oncodaily.com/event/ncoda-global-oncology-439449
LOCATION:The Shelbourne\, Autograph Collection\, 27 St Stephen's Green\, Dublin\, Leinster\, D02 K224\, Ireland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCODA-1.webp
ORGANIZER;CN="NCODA":MAILTO:contact@ncoda.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260406T055118
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260313
DTSTAMP:20260406T055118
CREATED:20251222T214739Z
LAST-MODIFIED:20251222T214750Z
UID:10000520-1773273600-1773359999@oncodaily.com
SUMMARY:The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer
DESCRIPTION:“The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer” is a specialized medical conference scheduled for March 12\, 2026\, in Bari\, Italy. \nThis educational event is designed specifically for healthcare professionals – including Pathologists\, Oncologists\, Biologists\, and Laboratory Technicians – to explore advanced diagnostic techniques that utilize biological fluids to identify genomic profiles and predict treatment responses without traditional tissue biopsies. \nRegister.
URL:https://oncodaily.com/event/liquid-biopsy-432811
LOCATION:Bari\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Liquid-Biopsy.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T055118
CREATED:20251105T200932Z
LAST-MODIFIED:20251105T200952Z
UID:10000324-1773273600-1773532799@oncodaily.com
SUMMARY:12th ImmunoTherapy of Cancer Conference (ITOC12)
DESCRIPTION:The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14\, 2026\, in Munich\, Germany. The conference provides a global platform focused on translational research in immuno-oncology\, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups\, including the ITOC Association\, the Tumor Centre in Munich (TZM)\, and the German Cancer Consortium (DKTK)\, the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.
URL:https://oncodaily.com/event/immunotherapy-403715
LOCATION:Medical Center Großhadern of Ludwig-Maximilian-University\, Marchioninistrasse 15\, Munich\, 81377\, Germany
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/Screenshot-2025-11-06-000822.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260316
DTSTAMP:20260406T055118
CREATED:20250918T121926Z
LAST-MODIFIED:20260106T085919Z
UID:10000241-1773273600-1773619199@oncodaily.com
SUMMARY:10th ESO SIOPE Masterclass in Paediatric Oncology
DESCRIPTION:The 10th ESO SIOPE Masterclass in Paediatric Oncology is scheduled on March 12-15\, 2026\, with the first block delivered online and the second block held in Barcelona\, Spain. It offers state-of-the-art plenary lectures\, interactive workshops\, tumor board simulations\, and case-based discussions with expert feedback. \nThe program is aimed at enhancing clinical management skills in childhood tumors\, leukemia\, and lymphoma\, applying the latest research findings to practice. Attendance is by application only\, with successful applicants granted free registration. The course also provides 30 ESCO credits for continuing medical education.
URL:https://oncodaily.com/event/eso-siope-345949
LOCATION:Hospital Sant Joan de Deu\, Pg. de Sant Joan de Déu\, 2\, 08950 Esplugues de Llobregat
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/G0-M3ipWQAAdUB-.jpeg
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260312T080000
DTEND;TZID=Europe/Zurich:20260314T170000
DTSTAMP:20260406T055118
CREATED:20250710T195346Z
LAST-MODIFIED:20250710T195614Z
UID:10000209-1773302400-1773507600@oncodaily.com
SUMMARY:The ESMO Sarcoma and Rare Cancers Congress 2026
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano\, Switzerland\, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. \nThe congress will discuss the latest developments in diagnosis\, treatment\, molecular biology\, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations\, educational lectures\, multidisciplinary tumour boards\, guidelines updates\, and dedicated discussions for young oncologists. With opportunities for clinicians\, researchers\, industry professionals\, and patient advocates to connect and collaborate\, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
URL:https://oncodaily.com/event/esmo-326996
LOCATION:“Palazzo dei Congressi” in Lugano\, Switzerland\, Piazza Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7057.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260313
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T055118
CREATED:20251204T111916Z
LAST-MODIFIED:20251204T120659Z
UID:10000442-1773360000-1773532799@oncodaily.com
SUMMARY:APPOS Boston 2026: Advanced Practice Providers Oncology Summit
DESCRIPTION:The APPOS Boston 2026: Advanced Practice Providers Oncology Summit returns to Massachusetts\, a two-day continuing education conference taking place March 13–14\, 2026\, in Waltham.  \nDesigned for advanced practice providers\, this program delivers the latest updates in multidisciplinary cancer care\, practical patient management\, and interprofessional collaboration. Attendees will have the opportunity to earn CE credits while gaining evidence-based strategies to enhance oncology practice and improve communication across the healthcare team. \nRegister.
URL:https://oncodaily.com/event/appos-boston-421264
LOCATION:The Westin Waltham Boston\, 70 Third Ave.\, Waltham\, MA\, 02451\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-2025-12-04T151840165-Picsart-AiImageEnhancer.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260313
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T055118
CREATED:20251119T215003Z
LAST-MODIFIED:20251119T215027Z
UID:10000376-1773360000-1773532799@oncodaily.com
SUMMARY:Inaugural Oncology Nursing Symposium 2026
DESCRIPTION:The Inaugural Oncology Nursing Symposium 2026\, hosted by the South Piedmont AHEC in conjunction with Advocate Health\, is a crucial two-day\, in-person event for nurses\, scheduled for March 13–14\, 2026. \nThe symposium will be held at the Embassy Suites by Hilton Charlotte Concord in Concord\, North Carolina. This educational gathering is aimed at a wide audience of oncology nurses\, including frontline clinicians\, nurse leaders\, educators\, and researchers\, and is accredited for a maximum of 7.50 ANCC contact hours. \nAgenda and Details. \nRegister.
URL:https://oncodaily.com/event/oncology-nursing-symposium-412819
LOCATION:Embassy Suites by Hilton Charlotte Concord Golf Resort & Spa\, 5400 John Q. Hammons Dr NW\, Concord\, NC\, 28027\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/Inaugural-Oncology-Nursing-Symposium-2026.png
ORGANIZER;CN="South Piedmont AHEC":MAILTO:charlotteahecpracticesupport@gaggle.email
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260314
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T055118
CREATED:20251201T195128Z
LAST-MODIFIED:20251201T195150Z
UID:10000432-1773446400-1773532799@oncodaily.com
SUMMARY:2026 CRUSH Colorectal Cancer 5K
DESCRIPTION:The CRUSH Colorectal Cancer 5K Walk/Run\, which supports research at the Duke Cancer Institute\, will take place on Saturday\, March 14\, 2026\, at 10:00 a.m. \nThe event will be held at The River Church. This event aims to raise awareness for colorectal cancer\, provide access to colorectal cancer screenings\, and feature community exhibitors.
URL:https://oncodaily.com/event/crush-colorectal-cancer-419939
LOCATION:The River Church\, 4425 Ben Franklin Blvd.\, Durham\, NC\, 27704\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Screenshot-2025-12-01-235030.webp
ORGANIZER;CN="Duke Cancer Institute":MAILTO:dcidevelopment@duke.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260314
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T055118
CREATED:20251215T192528Z
LAST-MODIFIED:20251215T192543Z
UID:10000499-1773446400-1773532799@oncodaily.com
SUMMARY:2026 OPN California - Hawaii Chapter Conference
DESCRIPTION:The 2026 OPN California – Hawaii Chapter Conference is a one-day regional summit organized by the Oncology Pharmacy Network (OPN) and Horizon CME\, scheduled for March 14\, 2026\, at the Sheraton Park Hotel at the Anaheim Resort in Anaheim\, California\, United States. \nThis event is specifically designed for hematology/oncology pharmacy clinicians (pharmacists\, pharmacy technicians\, and other healthcare professionals) and focuses on optimizing cancer care by providing the latest evidence-based strategies and fostering networking and collaboration within the community. \nRegister.
URL:https://oncodaily.com/event/opn-california-429044
LOCATION:Sheraton Park Hotel at the Anaheim Resort\, 1855 S Harbor Blvd\, Anaheim\, CA\, 92802\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-California.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260314
DTEND;VALUE=DATE:20260316
DTSTAMP:20260406T055118
CREATED:20260125T000227Z
LAST-MODIFIED:20260125T000300Z
UID:10000621-1773446400-1773619199@oncodaily.com
SUMMARY:Oncology Learning Network Great Debates in Solid Tumors\, Miami 2026
DESCRIPTION:The Oncology Learning Network Great Debates in Solid Tumors\, Miami 2026\, is a premier educational forum focused on advancing clinical knowledge and debating treatment standards in oncology. The first session is scheduled for March 14–15\, 2026\, in Miami\, followed by a second session from September 26–27\, 2026\, in New York City. \nOrganized by HMP Global\, this conference series features interactive debates and expert-led updates on key therapeutic areas\, including gastrointestinal\, lung\, breast\, gynecologic\, and genitourinary cancers. Designed for healthcare professionals\, researchers\, and industry members\, the meeting provides a platform to explore clinical evidence and innovative strategies aimed at improving patient outcomes in the rapidly evolving landscape of solid tumor management. \nRegister.
URL:https://oncodaily.com/event/oncology-learning-network-446547
LOCATION:Miami
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/OLN-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260315
DTEND;VALUE=DATE:20260319
DTSTAMP:20260406T055118
CREATED:20251114T215534Z
LAST-MODIFIED:20251114T215547Z
UID:10000358-1773532800-1773878399@oncodaily.com
SUMMARY:Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations
DESCRIPTION:The Keystone Symposia conference\, “Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations\,” will be held from March 15–18\, 2026\, at the Fairmont Le Château Frontenac in Québec City\, Québec\, Canada. \nThis meeting brings together leading experts from academia\, industry\, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance\, with the goal of guiding strategies to overcome these hurdles and improve clinical outcomes; the sessions will highlight emerging research on targeting stromal and myeloid cells\, tumor recognition\, and advanced technologies like spatial imaging and AI.
URL:https://oncodaily.com/event/cancer-immunotherapy-409811
LOCATION:Fairmont Le Château Frontenac\, 1 Rue des Carrières\, Québec\, Québec\, G1R 5J5\, Canada
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/Keynote-Symposia.jpg
ORGANIZER;CN="Keystone Symposia":MAILTO:info@keystonesymposia.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260317
DTSTAMP:20260406T055118
CREATED:20260313T130601Z
LAST-MODIFIED:20260313T130601Z
UID:10000692-1773619200-1773705599@oncodaily.com
SUMMARY:SIOP Webinar - Integrative Oncology in Pediatric Cancer Care
DESCRIPTION:The SIOP Global Health Network’s Traditional and Complementary Medicine Working Group is hosting an educational webinar\, “Integrative Oncology in Pediatric Cancer Care: Global Perspectives and 10 Years of Implementation\,” on Monday\, March 16\, 2026\, at 15:00 CET. \nLed by Dr. Ricardo Ghelman—a pediatric oncologist and member of the WHO Strategic Technical Advisory Group—the session examines the evolution of evidence-based traditional medicine within multidisciplinary teams over the last decade. The discussion will highlight strategies for safe integration in low- and middle-income countries\, the Brazilian academic experience\, and policy alignment with the WHO Global Strategy on Traditional Medicine 2025–2034. \nRegister.
URL:https://oncodaily.com/event/siop-468349
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Annotation-2026-03-13-170526-1.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260319
DTSTAMP:20260406T055118
CREATED:20251114T213627Z
LAST-MODIFIED:20251114T213641Z
UID:10000355-1773619200-1773878399@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO)\, focused on accelerating the delivery of life-changing anticancer therapies through early drug development. \nThe congress will be held from March 16 to 18\, 2026\, at the Palais des Congrès in Paris\, France. The event serves as a dynamic\, multi-stakeholder meeting\, uniting researchers\, industry leaders\, investors\, and regulators to share new data\, foster collaboration\, and tackle the challenges of advancing early clinical development in oncology. \nElena Garralda\, Carlos Gomez-Roca\, and Cristian Massacesi serve as the co-chairs.
URL:https://oncodaily.com/event/esmo-409793
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7078.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260320
DTSTAMP:20260406T055118
CREATED:20251103T202920Z
LAST-MODIFIED:20251103T202951Z
UID:10000316-1773705600-1773964799@oncodaily.com
SUMMARY:The Tumour Ecosystem: From Mechanisms to Novel Therapeutics
DESCRIPTION:The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo\, Italy. Organized by the European Association for Cancer Research (EACR)\, the event’s venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment\, covering how cancer cells interact with the immune system\, stroma\, and nervous system\, with the goal of developing new and efficient therapeutic strategies. \nYou can find more posts featuring EACR on OncoDaily.
URL:https://oncodaily.com/event/tumour-ecosystem-402728
LOCATION:Centro Congressi Giovanni XXIII\, Viale Papa Giovanni XXIII\, 106\, Bergamo\, Lombardy\, 24121\, Italy
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/TME26_slide_design.png
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260320
DTSTAMP:20260406T055118
CREATED:20251104T210200Z
LAST-MODIFIED:20251104T210211Z
UID:10000317-1773705600-1773964799@oncodaily.com
SUMMARY:From Protocol to Publication: A Practical Course in Clinical Research
DESCRIPTION:The “From Protocol to Publication: A Practical Course in Clinical Research” is an exclusive\, in-person training event organized by the European School of Oncology (ESO). Scheduled for 17 to 18 March 2026 in Milan\, Italy\, this advanced\, two-day workshop is reserved only for the ten members of the ESO College who achieve the highest scores in two prerequisite online courses. \nLed by Course Leaders Luca Bertolaccini (IT) and Isabelle Schmitt-Opitz (DE/CH)\, the course offers highly interactive sessions\, hands-on workshops\, and peer-review simulations designed to bridge the gap between theoretical knowledge and real-world research practice\, covering every phase from protocol design to publication strategies. \nYou can find more posts featuring ESO on OncoDaily.
URL:https://oncodaily.com/event/from-protocol-to-publication-403182
LOCATION:OR
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/College_Exclusive_4_copia_2.png
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260321
DTSTAMP:20260406T055118
CREATED:20251113T221317Z
LAST-MODIFIED:20251113T221334Z
UID:10000350-1773705600-1774051199@oncodaily.com
SUMMARY:TROG Annual Scientific Meeting 2026
DESCRIPTION:The 38th TROG Annual Scientific Meeting (ASM)\, hosted by the Trans-Tasman Radiation Oncology Group (TROG) Cancer Research\, will be held in Melbourne from March 17 to 20\, 2026. \nThe conference theme is “Driving Intelligent Trials\,” which focuses on using smarter designs\, AI-driven insights\, and stronger trial systems to achieve better research outcomes in radiation oncology. \nThe meeting’s sub-themes include: Precision and Performance (for smarter\, AI-enabled trial designs)\, Equity in Motion (for research involving consumers\, underserved\, rural\, and First Nations populations)\, and Fuelling the Future (for sustaining a strong research workforce and embedding research into clinical care). The ASM will serve as a key platform for collaboration\, learning\, and professional exchange on the latest developments in clinical trials and innovation in practice.
URL:https://oncodaily.com/event/trog-408959
LOCATION:Pullman Melbourne Albert Park\, 65 Queens Rd\, Albert Park VIC 3004\, Australia\, Melbourne\, Victoria\, 3004\, Australia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/TROG.jpg
ORGANIZER;CN="Trans-Tasman Radiation Oncology Group":MAILTO:membership@trog.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260318T130000
DTEND;TZID=America/Halifax:20260318T160000
DTSTAMP:20260406T055118
CREATED:20260312T123946Z
LAST-MODIFIED:20260312T123946Z
UID:10000691-1773838800-1773849600@oncodaily.com
SUMMARY:2026 SITC Autoimmunity and Immuno-Oncology Virtual Summit
DESCRIPTION:The Society for Immunotherapy of Cancer (SITC) will host the free\, open-door 2026 Virtual Summit on Autoimmunity and Immuno-Oncology on Wednesday\, March 18\, 2026\, from 1–4 p.m. EDT\, featuring program organizers Samik Basu (Cabaletta Bio)\, Marco Ruella (University of Pennsylvania)\, and Huji Xu (Naval Medical University and Tsinghua University) to highlight the emerging role of immunotherapies in treating autoimmune diseases. Expert faculty will provide an overview of the current state of knowledge\, mechanisms of toxicity\, and management strategies across different patient populations to foster collaboration between the immuno-oncology and rheumatology fields. \nRegister.
URL:https://oncodaily.com/event/immuno-oncology-467880
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-12T163714.279.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260406T055118
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260320T090000
DTEND;TZID=America/Halifax:20260320T100000
DTSTAMP:20260406T055118
CREATED:20260312T121023Z
LAST-MODIFIED:20260312T121023Z
UID:10000690-1773997200-1774000800@oncodaily.com
SUMMARY:Leukemia Maintenance Therapy: From Empiric Knowledge to New Paradigms - Resonance
DESCRIPTION:The ALRCaN (Acute Leukemia Research and Care Network) webinar\, titled “Maintenance therapy of leukemia – A journey from empiric knowledge to basic science and a novel paradigm\,” is scheduled for Friday\, March 20\, 2026\, from 05:00 to 06:00 PM (Armenia Standard Time). \nPresented by Kjeld Schmiegelow\, this session focuses on the evolution of maintenance therapy\, tracing its transition from empirical observations to deep basic science and the emergence of new therapeutic paradigms. This weekly collegial gathering\, hosted by Resonance\, allows experts to share best practices and clinical insights regarding leukemia and supportive care topics to optimize long-term patient outcomes.
URL:https://oncodaily.com/event/leukemia-467858
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Kjeld-Schmiegelow.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20260320T100000
DTEND;TZID=Australia/Melbourne:20260320T163000
DTSTAMP:20260406T055118
CREATED:20260222T124648Z
LAST-MODIFIED:20260222T124648Z
UID:10000664-1774000800-1774024200@oncodaily.com
SUMMARY:Thoracic Oncology Group of Australasia (TOGA) SCLC Masterclass 2026
DESCRIPTION:The Thoracic Oncology Group of Australasia (TOGA) will host its Small Cell Lung Cancer (SCLC) Masterclass on Friday\, March 20\, 2026\, at the Novotel Melbourne on Collins.  \nThis intensive\, face-to-face workshop is designed for healthcare professionals to navigate a pivotal turning point in SCLC management\, as novel therapies begin to challenge long-standing treatment paradigms. Chaired by A/Prof Surein Arulananda and Dr. Rebecca Tay\, the program features international insights from Dr. Maurice Perol (France) on molecular subtypes and new directions\, alongside Australian experts discussing limited-stage and extensive-stage standards of care. Through a combination of case studies and panel debates\, participants will explore emerging data on checkpoint inhibitors\, lurbinectedin\, and tarlatamab\, while addressing practical clinical challenges such as smoking cessation and the management of immune-related toxicities. \nRegister now.
URL:https://oncodaily.com/event/sclc-459535
LOCATION:Novotel Melbourne on Collins\, 270 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/Annotation-2026-02-22-164655-1.webp
END:VEVENT
END:VCALENDAR